1[1]Hering MD, Brendel B J, Schultz AO. International islet transplant registry newsletter[M]. Giessen: Justus-Liebig-University of Giessen,1999. 1-20.
2[2]Robertson RP, Davis C, Larsen J, et al. Pancreas and islet transplantation for patients with diabetes [J]. Diabetes Care, 2000, 23 (1):112-6.
3[3]Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen [J]. N Engl J Med, 2000, 343 (4):230-8.
4[4]Janjic D, Wollheim CB. Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetic assay[J]. Diabetologia, 1992, 35(5):482-5.
5[5]Fabian MC, Lakey JR, Rojotte RV, et al. The efficacy and toxicity of rapamycin in murine islet transplantation: in vitro and in vivo studies [J]. Transplantation, 1993, 56(5): 1137-42.
6[6]Paty BW, Harmon JS, Marsh CL, et al. Inhibitory effects ofimmunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets[J]. Transplantation, 2002, 73(3): 353-7.
5Ushitora Y, Tashiro H, Ogawa T, et al. Suppression of hepatocellular carcinoma recurrence after rat liver transplantation by FTY720, a sphingosine-1-phosphate analog [ J ]. Transplantation, 2009,88 ( 8 ) : 980.
6Troncoso P, Ortiz M, Martinez L, et al. FTY 720 prevents ischemic reperfusion damage in rat kidneys[ J ]. Transplant Proc, 2001, 33(1/2) :857.
7Durand P,Peralba P,Sierra F,et al.A new efficient synthesis of the immunosuppressive agent FTY-720[J].Synthesis,2000,15(4):505-6.
8Kiuchi M,Adachi K,Kohara T,et al.Synthesis and immunosuppressive activity of 2-substituted 2-amino propane-1,3-diols and 2-aminoethanols[J].J Med Chem,2000,43(15):2946-9.
9Fujita T,Sasaki S,Yoneta M,et al.2-Amino-1,3propanediol compound and immunosuppressant:WO 9408943[P].1994-08-09.
10Kalita B,Barua NC,Bez G,et al.Synthesis of 2-nitro alcohols by regioselective ring opening of epoxides with MgSO4/NeOH/NaNO2 system:a short synthesis of immunosuppressive agent FTY-720[J].Syn Lett,2001,91(4):11-3.
